News List

WuXi AppTec expands United States site to further drug development testing services


Chinese pharma major WuXi AppTec has expanded the Laboratory Testing Division (LTD) facility in New Jersey.

By Team ABLE

Chinese pharma major WuXi AppTec has expanded the Laboratory Testing Division (LTD) facility in New Jersey. The opening event was presided by state and local officials including State Senator Linda Greenstein. The new facility, according to the press statement, will enhance WuXi’s integrated testing service portfolio enabling drug developers to accelerate their projects from labs to patients.

The expansion is expected to double total operation space to more than 115,000 square feet, and could create over 200 jobs. After the expansion, LTD’s combined New Jersey operation will be one of its largest laboratories for preclinical and clinical drug development testing in the United States.

The new site will establish a center of excellence for drug development and provide high quality services to the US pharmaceutical and biotech industries. Furthermore, WuXi will recruit extensively from the local talent base, further contributing to economic growth locally.